Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A Common Pathway in Metabolic Syndrome

This article was originally published in Start Up

Executive Summary

A recent paper in Science is shedding new light on the possible origins of metabolic syndrome, supporting the notion that it can be traced to a well-defined cause and pathway and showing a link to coronary artery disease in the group studied. It also suggests that osteoporosis may be a risk factor for CAD. The work also shows how the study of rare genetic traits can provide clues to the mechanisms underlying more common forms of complex diseases.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC091370

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel